Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$887,191
+$285,204 QoQ
Shares Held
5,661
+43.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.67%
of 13F equity value
Holder Rank
#662
of 1,603 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aspen Wealth Management LLC holds $3,231,331 across 5 Drug Manufacturers - General names. NVS ranks #2 (27.5% of the industry book) .
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $887,191 | 5,661 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $601,987 | 3,941 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $543,345 | 3,941 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $637,994 | 4,975 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $510,904 | 4,222 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $470,668 | 4,222 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $410,842 | 4,222 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $485,614 | 4,222 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $449,474 | 4,222 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $408,394 | 4,222 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $427,910 | 4,238 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $431,682 | 4,238 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $427,656 | 4,238 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $391,000 | 4,250 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $385,560 | 4,250 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $378,833 | 4,984 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $359,252 | 4,250 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $372,937 | 4,250 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $371,747 | 4,250 | Shares | Sole | 2022-01-26 | |
| No filing history on record for this holder in this stock. | ||||||